Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

OPD - Charlemagne Capital - Replacement

30 Sep 2016 15:01

RNS Number : 3915L
Charlemagne Capital Limited
30 September 2016
Β 

Β 

The following replaces the 'Form 8 (OPD) Charlemagne Capital plc' released on 30 September 2016 at 07.00 under RNS No 2771L.

Β 

The opening two paragraphs in italics have been included and reference to Form "8" removed.

Β 

The full amended text is shown below:

Β 

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Β 

Charlemagne Capital has its registered office in Cayman and is not subject to the UK City Code on Takeovers and Mergers (the "Code"). Accordingly the Code does not apply to the Offer by Fiera Capital for Charlemagne Capital and this transaction is not subject to the jurisdiction of, or being regulated by, the UK Panel on Takeovers and Mergers (the "Takeover Panel"). However, Charlemagne Capital and Fiera Capital have agreed, to the extent set out in the Implementation Agreement, that they will conduct themselves and the Offer as if the Offer were subject to the Code.

Β 

Disclosures made in relation to relevant securities of Charlemagne Capital should be released via a Regulatory Information Service using the headline "Document re: Charlemagne Capital". The headline "Form 8/8.3"should not be used. Any question regarding completion of these forms should be raised with N+1 Singer (tel: +44 (0) 20 7496 3000). Charlemagne Capital Shareholders and persons considering the acquisition or disposal of any interest in Charlemagne Capital Shares are reminded that they are subject to the Disclosure and Transparency Rules made by the UKLA and other applicable regulatory rules regarding transactions in Charlemagne Capital Shares.

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Charlemagne Capital Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Charlemagne Capital Limited

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

27 September 2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

Β 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

Β 

TOTAL:

Nil

Nil

Nil

Nil

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

Interests held by directors of Charlemagne Capital Limited:

Β 

Director

Shareholding

Percentage holding

James Mellon(1)

55,669,497

19.14

Jayne Sutcliffe(2)

31,708,519

10.90

Jane McAndry

1,266,719

0.44

Lloyd Jones

1,196,938

0.41

Michael Baer

800,000

0.28

Jacob Johan (Jaap) van Duijn

200,000

0.07

Rt Hon Lord Lang of Monkton, PC

100,000

0.03

Β 

(1) A number of shares included in this holding are held by Galloway Limited, Indigo Securities Limited and Burnbrae Limited, which are each indirectly wholly owned by the trustee of a settlement under which James Mellon has a life interest.

(2) A number of shares included in this holding are held on behalf of the trustees of discretionary trusts, under which Jayne Sutcliffe and members of her family may become beneficiaries.

Β 

Interests held by directors of subsidiary companies wholly owned by Charlemagne Capital Limited:

Β 

Director

Shareholding

Percentage holding

Varda Lotan3

4,107,924

1.41

Anderson Whamond4

3,200,000

1.10

Julian Mayo

1,457,864

0.50

Vicky Kydoniefs

371,511

0.13

Β 

(3) A number of shares included in this holding are held on behalf of the trustees of discretionary trusts, under which Varda Lotan and members of her family may become beneficiaries.

(4) A number of shares included in this holding are held on behalf of the trustees of a pension plan, under which Anderson Whamond and members of his family may become beneficiaries.

Β 

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form (Open Positions)

NO

Supplemental Form (SBL)

NO

Β 

Β 

Date of disclosure:

30 September 2016

Contact name:

Jane McAndry

Telephone number:

01624 640 216

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEEWGUAABUPQGWU
Date   Source Headline
17th Sep 20079:42 amRNSTransaction in Own Shares
13th Sep 200711:29 amRNSDirector/PDMR Shareholding
13th Sep 20079:43 amRNSTransaction in Own Shares
13th Sep 20079:40 amRNSDirector/PDMR Shareholding
12th Sep 20077:01 amRNSAfrica Fund B Share Launch
10th Sep 20079:05 amRNSDirector/PDMR Shareholding
7th Sep 20079:21 amRNSDirector/PDMR Shareholding
5th Sep 20075:07 pmRNSDirector/PDMR Shareholding
5th Sep 20074:58 pmRNSDirector/PDMR Shareholding
4th Sep 20077:02 amRNSDividend Declaration
4th Sep 20077:01 amRNSInterim Results
31st Aug 20077:00 amRNSCompany Secretary Change
23rd Aug 20077:00 amRNSNotice of Interim Results
22nd Aug 200712:34 pmRNSBulgaria JV Development Agmt
17th Aug 20073:03 pmRNSAIM Rule 26
14th Aug 20079:00 amRNSNotice of EGM
1st Aug 20077:02 amRNSDisposal of Properties
10th Jul 20077:00 amRNSTrading Update
28th Jun 20077:01 amRNSTransaction in Own Shares
27th Jun 20077:03 amRNSMagna Africa Fund AuM
20th Jun 20077:01 amRNSCharlemagne ECDC Placing
31st May 20077:01 amRNSTransaction in Own Shares
30th May 20077:01 amRNSECDC Intention to Float
17th May 20077:00 amRNSTransaction in Own Shares
14th May 200712:35 pmRNSResult of AGM
14th May 20077:01 amRNSAGM Statement
30th Apr 20077:05 amRNSEastern European Hedge Fund
25th Apr 20077:00 amRNSTransaction in Own Shares
20th Apr 20074:42 pmRNSHolding(s) in Company
20th Apr 20079:21 amRNSHolding(s) in Company
12th Apr 20077:00 amRNSTransaction in Own Shares
10th Apr 200711:17 amRNSHolding(s) in Company
10th Apr 20077:01 amRNSDirector/PDMR Shareholding
10th Apr 20077:01 amRNSTransaction in Own Shares
5th Apr 20077:01 amRNSQ1 AuM Update
2nd Apr 20077:01 amRNSDirector/PDMR Shareholding
30th Mar 20074:01 pmRNSHolding(s) in Company
26th Mar 20077:01 amRNSTransaction in Own Shares
23rd Mar 20077:00 amRNSTransaction in Own Shares
13th Mar 200712:43 pmRNSDividend Declaration
13th Mar 20077:02 amRNSFinal Results
26th Feb 20078:54 amRNSNaya Bharat Property Company
22nd Jan 200710:30 amRNSNotice of Results
12th Jan 20077:00 amRNSTrading Statement
25th Oct 20067:01 amRNSTransaction in Own Shares
20th Oct 20067:00 amRNSTransaction in Own Shares
13th Oct 20067:01 amRNSAppointment
6th Oct 20067:00 amRNSAuM update
13th Sep 20067:04 amRNSPrivate Equity Property Fund
4th Sep 20067:02 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.